Third Point buys stake in Spanish defence firm Indra, source says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Item 1 of 2 Dan Loeb, CEO and founder of Third Point, speaks during the 13D Monitor's Active-Passive Investor Summit in New York City, U.S., October 18, 2022. REUTERS/Brendan McDermid[1/2]Dan Loeb, CEO and founder of Third Point, speaks during the 13D Monitor's Active-Passive Investor Summit in New York City, U.S., Octo ...

Core Viewpoint - Hedge fund D.E. Shaw is advocating for significant changes at CoStar Group, including a board shake-up, due to concerns over the company's underperformance and its investment strategy [1][3]. Group 1: Company Performance and Strategy - D.E. Shaw attributes CoStar's share underperformance to its "high-risk, money-losing" investment in Homes.com, which aggregates home listings [2]. - CoStar's market value is approximately $22 billion, with shares down over 23% year-to-date, partly due to investor concerns about overspending and increased competition [6]. - D.E. Shaw criticizes CoStar's current leadership, particularly Andrew Florance, for being tied to the unsuccessful Homes.com strategy and claims the board is failing in its oversight responsibilities [5]. Group 2: Proposed Changes - D.E. Shaw is calling for CoStar to monetize Homes.com, refocus on its core business, initiate stock buybacks, and restructure executive compensation [5]. - While D.E. Shaw has not explicitly stated plans for a proxy fight, it has left the possibility open in its communications [5]. Group 3: Company Background - CoStar, founded in the 1980s by Andrew Florance, has established itself as a leading provider of commercial real estate data, expanding its offerings over the years to include various property types [4]. - The company's recent expansion into the single-family housing market through Homes.com has been met with challenges, particularly from established competitors like Zillow Group and Realtor.com [5].

Core Viewpoint - CoStar is currently under pressure from Daniel Loeb's Third Point, indicating potential challenges for the company in maintaining its market position and performance [1] Group 1 - CoStar is facing scrutiny from Third Point, which may impact its strategic decisions and operational focus [1]

Core Viewpoint - CoStar Group is committed to prioritizing profitable growth and enhancing long-term value for shareholders, responding to feedback from major shareholders, including Third Point, by implementing a series of strategic initiatives aimed at improving profitability and transparency [2][3]. Strategic Initiatives - The Board has recommended a plan to accelerate profitability for Homes.com, invest in core platforms, return capital to shareholders, align executive compensation with shareholder interests, and enhance investor transparency [3][5]. - A Capital Allocation Committee has been formed to review the company's capital structure and investment priorities, including significant investments in major brands like CoStar and Apartments.com [5]. - The company plans to moderate investment in Homes.com, reducing net investment by $300 million in 2026 and over $100 million annually thereafter, aiming for breakeven profitability by the end of 2029 [5][6]. Financial Performance and Projections - CoStar Group expects revenue of $3.8 billion in 2026, an 18% increase from 2025, with adjusted EBITDA projected to rise 83% to $770 million, achieving a margin of 20% compared to 13% in 2025 [8]. - The company anticipates entering a new phase of accelerated, profitable growth, with a long-term goal of achieving adjusted EBITDA of $2.3 billion and a margin of 35% by 2030 [9]. Market Position and Growth - Homes.com is showing strong momentum, with a 337% increase in subscribers since Q1 2024, and is expected to scale rapidly while lowering capital intensity [6]. - The company has a proven track record of successful acquisitions, having acquired over 40 businesses for approximately $7.3 billion, generating internal rates of return (IRRs) between 17% and 39% [7]. Shareholder Returns - CoStar Group has delivered approximately 290% total shareholder returns over the last 10 years, significantly outperforming the median of its real estate marketplace peers [14]. - The company is accelerating its $500 million share repurchase program initiated in 2025 and has authorized a new $1.5 billion repurchase program in January 2026 [5].

格隆汇1月27日｜据路透，亿万富翁投资者Daniel Loeb的对冲基金Third Point正准备对房地产数据公司 CoStar Group发起激进投资活动。报道称，Third Point计划提名数名董事加入CoStar八人董事会，作为迫 使这家市值280亿美元公司进行变革的一部分。该对冲基金希望CoStar专注于其核心商业房地产业务， 同时关闭或出售近年来为与Zillow Group竞争而扩展的住宅业务。此外，Third Point还寻求削减成本， 包括CEO薪酬，并计划替换CoStar大部分董事会成员，以帮助提振公司股价。 ...

With its first activist campaign in three years, hedge fund Third Point will try to force CoStar Group , the owner of Apartments.com and Homes.com, to change board directors and restructure operation... ...

Core Insights - Third Point's Offshore Fund returned 3.2% net in Q3, underperforming compared to the S&P 500 Index which returned 8.1% [2][3] - The fund's annualized return since inception is 13.2%, indicating strong long-term performance despite recent quarterly challenges [3] Portfolio Performance - Top five winners for the quarter included TSMC, Nvidia, CRH PLC, Comfort Systems USA, and Pacific Gas and Electric [4] - Major losses were seen in Kenvue, DSV A/S, Primo Brands, London Stock Exchange Group, and Flutter Entertainment, with overall performance below expectations due to weak event-driven positions [4] Market Trends - The equity market in 2025 is characterized by increasing concentration, particularly in gold and AI-related stocks, with structural problems noted in various sectors [5] - The demand for AI compute has accelerated, driven by advancements in model architectures and user engagement, benefiting investments in semiconductor companies like TSMC and Nvidia [6][8] Investment Opportunities - Third Point has invested in SK Hynix and Ebara, viewing them as undervalued leaders in their respective sectors, particularly benefiting from the AI buildout [9][12] - SK Hynix holds over 50% market share in high bandwidth memory (HBM), which is expected to grow significantly, contributing to a larger portion of the company's revenue [10][11] - Ebara is positioned well in the semiconductor production equipment market, particularly with its CMP tools, which are critical for advanced semiconductor manufacturing [13][14] Credit Market Insights - The credit market has shown resilience, with specific distressed trading opportunities arising from events in the subprime auto sector [17][18] - Third Point's corporate credit strategy has rebounded, achieving a 4.0% gross return in Q3, with significant contributions from companies like Michaels and exposure to Elon Musk's ventures [20][23] Business Updates - New team members have joined the equities team, enhancing the firm's analytical capabilities [29]

Core Points - New York City mayoral candidate Zohran Mamdani faces significant opposition from billionaires who have financially supported his opponents [1][2] - Mamdani's campaign has been targeted with over $22 million in donations aimed at undermining his candidacy [3] Group 1: Opposition Funding - 26 billionaires and members of wealthy families have each contributed at least $100,000 to support Mamdani's opponents [2] - Major contributions include: - Michael Bloomberg: $8.3 million to Fix the City [3] - Joseph Gebbia: $3 million to various anti-Mamdani groups [4] - Lauder family: $2.6 million in total [5][6] - Bill Ackman: $1.75 million to anti-Mamdani PACs [8] - Tisch family: $1.2 million in total [9][10] - John Hess and family: $1 million to Fix the City [11] - Daniel Loeb: $775,000 to Fix the City [12] - Barry Diller: $500,000 to Fix the City [13] - Steve Wynn: $500,000 to Fix the City [14] - Marcella Guarino Hymowitz: $400,000 to anti-Mamdani campaigns [15] Group 2: Additional Donors - Other notable billionaire donors include: - David Walentas: $350,000 [17] - Reed Hastings: $250,000 [17] - John Fish: $250,000 [17] - Alice Walton: $200,000 [17] - Deborah Simon: $200,000 [17] - Jerry Speyer: $150,000 [17] - Stephanie Coleman: $150,000 [17] - The Durst family: $110,000 [17] - The Fisher family: $110,000 [17] - Ken Langone: $100,000 [17] Group 3: Election Timeline - Early voting for the New York City mayoral election began on October 4, with election day set for November 4 [18]

Core Insights - Kenvue, the maker of Tylenol, has faced significant challenges in 2023, including activist investor pressure and negative publicity related to its products [1][5] - The company has experienced a substantial decline in market value, losing approximately $10 billion following controversial statements from the Trump administration regarding Tylenol's safety [5] Group 1: Company Developments - Kenvue's board underwent significant changes, including the ousting of its CEO and CFO, as well as the appointment of directors from activist investor Starboard Value [2] - A strategic review of Kenvue's operations has been initiated, which may involve a potential sale or breakup of the company [2] Group 2: Market Impact - Following the release of claims linking Tylenol to autism, Kenvue's shares dropped by 9% in a single day [3] - The company's market value is now approximately $30 billion, indicating a significant loss of investor confidence due to recent events [5] Group 3: Regulatory and Legal Challenges - The FDA issued a new warning on Tylenol labels, citing potential risks associated with its active ingredient, acetaminophen, during pregnancy [4] - Ongoing legal challenges include appeals related to lawsuits claiming Tylenol caused autism, which have previously been dismissed for lack of scientific evidence [6]

Core Viewpoint - Kenvue, the consumer health spinoff from Johnson & Johnson, is facing significant challenges, including a recent stock decline due to controversial claims regarding Tylenol and ongoing activist investor pressure [1][4][13] Company Overview - Kenvue was established as the world's largest pure-play consumer health company after its separation from Johnson & Johnson in August 2023, allowing J&J to focus on Pharmaceuticals and MedTech [2] - The company boasts strong brands like Tylenol, Band-Aid, Neutrogena, Aveeno, and Listerine, which are positioned as reliable cash-flow generators for dividend-focused investors [2][10] Recent Controversies - The stock price of Kenvue dropped over 7% intraday following allegations from President Trump and Robert F. Kennedy Jr. that Tylenol use during pregnancy could lead to autism, despite these claims being dismissed by the FDA and medical experts [1][4] - The controversy surrounding Tylenol has raised concerns about consumer perception, healthcare guidance, and potential litigation, particularly as Tylenol is Kenvue's flagship product [5][11] Leadership and Governance - Kenvue's CEO Thibaut Mongon was ousted in July 2025 due to criticism over company execution, particularly in the Skin Health & Beauty division, with Kirk Perry appointed as interim CEO [6] - The leadership change followed a proxy settlement with activist investor Starboard Value, which gained three board seats and has been pushing for strategic changes [7] Activist Investor Pressure - Activist investors, including Starboard, Third Point, and TOMS Capital, are advocating for cost-cutting measures, portfolio focus, and strategic alternatives if performance does not improve [8] - The recent Tylenol controversy is viewed by activists as indicative of Kenvue's lack of resilience, emphasizing the need for a new approach to enhance returns [9] Financial Performance and Market Position - Kenvue reported over $15 billion in annual revenue and has a strong global distribution network, with leading market positions in pain relief and other consumer health categories [10] - Despite strong fundamentals, the company faces volatility in stock performance due to shifts in consumer trust and perception, particularly in light of the recent allegations against Tylenol [11] Future Considerations - Investors are advised to monitor retail sales data, healthcare guidance changes, and the ongoing activist campaigns as indicators of Kenvue's market performance and consumer demand [15]